1-4 of 4
Wendy B. Young
Close
Sort by
Journal Articles

Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL

Sean D. Reiff, Elizabeth M. Muhowski, Daphne Guinn, Amy Lehman, Catherine A. Fabian, Carolyn Cheney, Rose Mantel, Lisa Smith, Amy J. Johnson, Wendy B. Young, Adam R. Johnson, Lichuan Liu, John C. Byrd, Jennifer A. Woyach
Journal: Blood
Blood (2018) 132 (10): 1039–1049.
https://doi.org/10.1182/blood-2017-10-809020
Published: 2018
Journal Articles

A Selective Small Molecule Factor VIIa Inhibitor, CRA-027483, Suppresses Acute Inflammation in Mice.

Stacie A. Dalrymple, PhD, Florentino D. San Pablo, Juthamas Sukbuntherng, PhD, James W. Janc, PhD, Wendy B. Young, PhD, Dange Vijaykumar, PhD, Heleen Scheerens, PhD
Journal: Blood
Blood (2005) 106 (11): 3089.
https://doi.org/10.1182/blood.V106.11.3089.3089
Published: 2005
Journal Articles

Subcutaneous Dosing of CRA-027483, a Small Molecule FVIIa Inhibitor, Prevents Arterial Thrombosis in a Baboon Model.

Ulla M. Marzec, Juthamas Sukbuntherng, Ph.D, Stacie A. Dalrymple, Ph.D, Wendy B. Young, Ph.D, Dange Vijaykumar, PhD, Peter R. Young, Ph.D, Stephen R. Hanson, PhD
Journal: Blood
Blood (2005) 106 (11): 1867.
https://doi.org/10.1182/blood.V106.11.1867.1867
Published: 2005
Journal Articles

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Pamela A. Davol, MEd, Jonathan M. Gall, BS, Ryan C. Grabert, BS, Wendy B. Young, RN, OCN, Francis J. Cummings, MD, Ritesh Rathore, MD, Gerald A. Colvin, DO, Gerald J. Elfenbein, MD, Lawrence G. Lum, MD, DSc
Journal: Blood
Blood (2004) 104 (11): 1349.
https://doi.org/10.1182/blood.V104.11.1349.1349
Published: 2004